Brain stimulation for treatment-resistant depression
Part of Mental health clinical trials.
This study tests a type of brain stimulation called cTBS (continuous theta burst stimulation) applied to a specific part of the brain (the precuneus) to see if it helps with treatment-resistant depression. It aims to provide a new option for people who haven't found relief from standard treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old and able to read and understand English.
- You must have a diagnosis of major depressive disorder (often called clinical depression).
- Your depression must be considered treatment-resistant, meaning at least two different antidepressants have not worked well enough.
- Your depression must be at least moderately severe, as measured by a standard questionnaire (score of 10 or higher).
- You cannot have certain safety risks, such as a history of seizures, stroke, metal in your head, or implanted devices like a pacemaker.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether certain substances in the blood can help predict how well a type of brain stimulation called intermittent theta burst stimulation (iTBS) works for people whose depression hasn't improved with standard treatments. It may help doctors choose better treatments in the future.
This study tests whether a gentle brain stimulation technique called tDCS can help people with depression that hasn't improved with medication. It can be done at home using a special headset and an internet connection.
This study compares two fast types of brain stimulation (called accelerated theta burst stimulation) to see which works better for people whose depression hasn't improved with standard antidepressants. It's designed for people with treatment-resistant depression who are already on a stable antidepressant.
This trial tests a personalized brain stimulation method called neuronavigated aiTBS for people with depression that hasn't improved with at least two prior treatments. The goal is to see if this therapy can safely and effectively reduce depressive symptoms.
This trial tests whether repeated magnetic brain stimulation (rTMS) can help people with depression that hasn't improved with standard treatment. Participants must be taking a specific antidepressant and be right-handed.
This study uses a special type of brain stimulation (rTMS, which uses magnetic pulses) to treat depression. It focuses on part of the brain called the orbitofrontal cortex and aims to understand how stimulating it helps improve mood.
Hear when a new Depressive Disorder, Treatment-Resistant trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.